Literature DB >> 10431663

Bile acids and lipoprotein metabolism: a renaissance for bile acids in the post-statin era?

B Angelin1, M Eriksson, M Rudling.   

Abstract

Based on an improved molecular understanding of how bile acid metabolism is regulated, an exciting period of research developments can be expected. By new ways of stimulating cholesterol breakdown to bile acids, novel therapeutic principles can be forseen which will further improve our potential for treating and preventing atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10431663     DOI: 10.1097/00041433-199906000-00009

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  4 in total

1.  Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels.

Authors:  Laurent Vergnes; Jessica M Lee; Robert G Chin; Johan Auwerx; Karen Reue
Journal:  Cell Metab       Date:  2013-06-04       Impact factor: 27.287

2.  Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype.

Authors:  Clive R Pullinger; Celeste Eng; Gerald Salen; Sarah Shefer; Ashok K Batta; Sandra K Erickson; Andrea Verhagen; Christopher R Rivera; Sean J Mulvihill; Mary J Malloy; John P Kane
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

3.  A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation.

Authors:  William D Chey; Michael Camilleri; Lin Chang; Leif Rikner; Hans Graffner
Journal:  Am J Gastroenterol       Date:  2011-05-24       Impact factor: 10.864

4.  Specific inhibition of bile acid transport alters plasma lipids and GLP-1.

Authors:  Mats Rudling; Michael Camilleri; Hans Graffner; Jens Juul Holst; Leif Rikner
Journal:  BMC Cardiovasc Disord       Date:  2015-07-22       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.